B + L marks 40th anniversary of soft contact lenses

Article

Soft contact lenses have become America's predominant form of contact lens vision correction and radically changed the way patients expect to manage their vision care.

Rochester, NY-In the early 1960s, as Americans grappled with a firestorm of societal changes, a Czech professor tinkered behind the Iron Curtain with a novel material he hoped would provide clear, comfortable vision without spectacles.

The story of how Otto Wichterle, PhD, used his children's erector set, bicycle parts, a hot plate, and the motor from a record player to spin hydroxyethyl methacrylate (HEMA) into thin discs has become legendary.

But from that simple spin-cast system, Dr. Wichterle sparked what would become America's predominant form of contact lens (CL) vision correction and radically change the way patients expect to manage their vision care. Dr. Wichterle's patents to develop the material and lens were eventually sold to Bausch + Lomb (B + L), which refined the technology and introduced the first hydrogel contact lens (HCL) in 1971.

"It really was a transformation," said Joseph T. Barr, OD, MS, FAAO, vice president, global clinical and medical affairs and professional services, vision care, B + L.

A little history

In 1936, William Feinbloom, OD, experimented with CLs made with polymethyl methacrylate (PMMA). The plastic was lighter and easier to manufacture than glass, but its scleral design blocked oxygen.

About 10 years later, California optician Kevin Tuohy accidentally cut a scleral lens down too far and produced the first corneal lens. "That opened the door, because these were easier to make, easier to handle, easier to wear, and better for the eye because you'd get some tears coming in from the edge to provide oxygen," said Edward S. Bennett, OD, associate professor, University of Missouri-St. Louis College of Optometry, and co-chief of its CL service.

Recent Videos
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
Kerry Giedd, OD, MS, FAAO, was 1 of 20 investigators around the country for a study evaluating the daily disposable contact lens.
According to A. Paul Chous, MA, OD, FAAO, optometrists have an important opportunity to educate patients in their chairs about diabetes.
David Geffen, OD, FAAO, gave a poster presentation titled "Revolutionizing Comfort: Unveiling the Potential of Perfluorohexyloctane Eyedrops for Contact Lens Wearers" at this year's Academy meeting.
Jessica Steen, OD, FAAO, Dipl-ABO, discussed ophthalmic considerations for patients undergoing treatment with antibody drug conjugates for gynecologic cancers at this year's conference.
A. Paul Chous, MA, OD, FAAO, details a presentation on this year's updates on diabetes given at this year's Academy meeting
Sherrol Reynolds, OD, FAAO, said that multimodel imaging has been a game changer in assessing the choroidal function and structural changes in various disease conditions.
Susan Gromacki, OD, FAAO, FSLS, provides key takeaways from this year's American Academy of Optometry symposium genetics and the cornea.
Roya Attar gives an overview of her presentation, "Decoding the Retina: The Value of Genetic Testing In Inherited Disorders," presented with Mohammad Rafieetary, OD, FAAO, FORS, ABO, ABCMO.
Ian Ben Gaddie, OD, FAAO, outlines key findings from a recent study evaluating lotilaner in patients with Demodex blepharitis and meibomian gland dysfunction.
© 2024 MJH Life Sciences

All rights reserved.